The FDA approved the first drug designed to delay congestive heart failure in dogs The medication targets dogs with early heart disease before symptoms develop Early treatment may improve lifespan and ...
The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results